Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

Inclusion Criteria: * Male or female patients \> 18 years of age, who have been prescribed 0.5% Moxifloxacin drops preoperatively and postoperatively for 2 weeks after ocular Surgery * Patient or legally acceptable representative (LAR) willing to voluntarily provide signed informed consent for participation in the study Exclusion Criteria: * Patients with known history of hypersensitivity to fluoroquinolones * Patients with history of serious underlying ocular or systemic disease or complication before surgery * Patients diagnosed with an extraocular bacterial, viral, fungal infection prior to surgery * Patients who have been administered other topical antibacterial agents within 24 hours of Moxifloxacin administration or systemic antibacterial agents within 72 hours of Moxifloxacin administration * Patients who have planned to undergo cataract surgery in both eyes on same day * Patients who have participated in another clinical study within 30 days prior to the start of this study * Pregnant women/lactating mothers/ women suspected to be pregnant